Suppresses non-specific amplification, achieving high specificity and high sensitivity in PCR! Real-time PCR master mix (SYBR Green I detection system)
This is a master mix for real-time PCR (2× concentration). It features a chemically modified hot-start DNA polymerase and optimized buffer to suppress non-specific amplification, achieving high specificity and reproducibility. Additionally, by adding the separately sold Uracil-N-Glycosylase (UNG), carryover prevention treatment can be performed. <Features> ◎ Outstanding cost performance ◎ High specificity and amplification efficiency ◎ Carryover prevention with the addition of UNG (*) ◎ Compatible with various real-time PCR devices (pre-adjusted with dye for calibration) * This product does not contain Uracil-DNA Glycosylase (UNG). * For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Product Information】 Product Name: GeneAce SYBR(TM) qPCR Mix II Packaging: For 500 reactions (1.25mL x 4 tubes) For 125 reactions (1.25mL x 1 tube) Caution: - Since this product uses a chemically modified hot-start PCR enzyme, please be sure to perform the enzyme activation step (95℃ for 10 minutes). - This product does not contain UNG. If UNG treatment is required, you can use the separately sold Uracil-DNA Glycosylase (UNG) (Code No. 317-09041).
Price range
Delivery Time
Applications/Examples of results
Real-time quantitative PCR
catalog（1）
Download All Catalogs
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.